Joint comfort and cartilage support

Glucosamine Sulfate

Long-term trial and meta-analytic evidence suggest modest symptom relief in osteoarthritis, with heterogeneity across formulations.

Evidence Level B

Evidence and Risk Labels

Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.

See full scoring guide

Clinical Snapshot

Effect Size
Modest pain and function improvement in selected OA populations
Safety
Low Risk

Response varies and benefit tends to accumulate gradually over months.

Research Dosing

This reflects common ranges and protocols used in published studies, not personal medical advice.

Typical Daily Dose
1500 mg
Timing
Daily with meals
Protocol Duration in Studies
8-24 weeks in common musculoskeletal studies

Consistency over time is usually required for detectable benefit.

Best Fit Profiles

  • long-horizon joint support strategies

Source Links